In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...

A fault in J&J MedTech’s CEREPAK detachable coils, used in intracranial aneurysm embolisation procedures, has been associated ...

This stock has climbed in the triple digits in recent years.

Medtech startups struggle with funding as strategic buyers consolidate, preferring fully developed products over early ...

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of J&J’s ...

Coherent Sine-Burst Electroporation™ Platform demonstrates 100% procedural success and high freedom from AF in paroxysmal and persistent ...

The context-aware, multi-lingual AI agents act like a 24/7 digital FDA reviewer, helping MedTech companies improve ...

Johnson & Johnson MedTech (NYSE:JNJ) today announced 12-month pilot data from a study of its investigational Omnypulse ...

Founder and CEO Christian Espinosa Will Join Panel on Data Governance and Patient Safety for Scalable HealthTech in the ...

Argá Medtech today announced positive findings from a first-in-human study of its Coherent Sine-Burst Electroporation (CSE) system.

Med-tech companies looking for capital will have to work harder this year to attract investor attention. Even though investment firms have money to deploy, the capital will go toward more targeted ...